BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sultan A, Ali R, Sultan T, Ali S, Khan NJ, Parganiha A. Circadian clock modulating small molecules repurposing as inhibitors of SARS-CoV-2 Mpro for pharmacological interventions in COVID-19 pandemic. Chronobiol Int 2021;38:971-85. [PMID: 33820462 DOI: 10.1080/07420528.2021.1903027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Cao J, Gong Y, Wu M, Xiong L, Chen S, Huang H, Zhou X, Peng Y, Shen X, Qu J, Wang Y, Zhang X. Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.1044770] [Reference Citation Analysis]
2 Skrlec I, Talapko J. Hepatitis B and circadian rhythm of the liver. World J Gastroenterol 2022; 28(27): 3282-3296 [DOI: 10.3748/wjg.v28.i27.3282] [Reference Citation Analysis]
3 Ahmad Bhat S, Islam Siddiqui Z, Ahmad Parray Z, Sultan A, Afroz M, Ali Azam S, Rahman Farooqui S, Naqui Kazim S. Naturally occurring HMGB1 inhibitor delineating the anti-hepatitis B virus mechanism of glycyrrhizin via in vitro and in silico studies. Journal of Molecular Liquids 2022;356:119029. [DOI: 10.1016/j.molliq.2022.119029] [Reference Citation Analysis]
4 Gao K, Wang R, Chen J, Cheng L, Frishcosy J, Huzumi Y, Qiu Y, Schluckbier T, Wei X, Wei GW. Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chem Rev 2022. [PMID: 35594413 DOI: 10.1021/acs.chemrev.1c00965] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
5 Blanco JR, Verdugo-Sivianes EM, Amiama A, Muñoz-Galván S. The circadian rhythm of viruses and its implications on susceptibility to infection. Expert Rev Anti Infect Ther 2022;:1-9. [PMID: 35546444 DOI: 10.1080/14787210.2022.2072296] [Reference Citation Analysis]
6 Boreak N, Bhandi S. In-Silico modulation of Interleukin-8 (IL8) for the therapeutic management of endodontic pulpitis. Saudi Journal of Biological Sciences 2022;29:905-10. [DOI: 10.1016/j.sjbs.2021.10.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Albaz AA, Rafeeq MM, Sain ZM, Almutairi WA, Alamri AS, Aloufi AH, Almalki WH, Tarique M. Nanotechnology-based approaches in the fight against SARS-CoV-2. AIMS Microbiol 2021;7:368-98. [PMID: 35071938 DOI: 10.3934/microbiol.2021023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Jha P, Singh P, Arora S, Sultan A, Nayek A, Ponnusamy K, Syed MA, Dohare R, Chopra M. Integrative multiomics and in silico analysis revealed the role of ARHGEF1 and its screened antagonist in mild and severe COVID-19 patients. J Cell Biochem 2022. [PMID: 35037717 DOI: 10.1002/jcb.30213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lauwers M, Au M, Yuan S, Wen C. COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives. Int J Mol Sci 2022;23:720. [PMID: 35054906 DOI: 10.3390/ijms23020720] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
10 Jones MK, Almand EA, Soorneedi A, Moore MD. Eukaryotic Virus Interactions with Bacteria: Implications for Pathogenesis and Control. The Biological Role of a Virus 2022. [DOI: 10.1007/978-3-030-85395-2_10] [Reference Citation Analysis]
11 McNaughton CD, Adams NM, Hirschie Johnson C, Ward MJ, Schmitz JE, Lasko TA. Diurnal Variation in SARS-CoV-2 PCR Test Results: Test Accuracy May Vary by Time of Day. J Biol Rhythms 2021;36:595-601. [PMID: 34696614 DOI: 10.1177/07487304211051841] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
12 Sultan A, Ali R, Ishrat R, Ali S. Anti-HIV and anti-HCV small molecule protease inhibitors in-silico repurposing against SARS-CoV-2 Mpro for the treatment of COVID-19. J Biomol Struct Dyn 2021;:1-15. [PMID: 34569411 DOI: 10.1080/07391102.2021.1979097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Boreak N. Small Molecule "Silmitasertib" Repurposed as Inhibitor of Transforming Growth Factor Beta 1 for the Development of Therapeutics for Oral Submucous Fibrosis. Biomed Res Int 2021;2021:6631848. [PMID: 33869629 DOI: 10.1155/2021/6631848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]